It’s time to start innovating to make administrative data interoperable

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES It's time to start innovating to make administrative data interoperable Just as with clinical interoperability, greater administrative interoperability could help eliminate many of the costs related to billing and insurance, freeing up much-needed investment resources. Sponsored Content Using AI to reduce false alerts for patientswith heart monitoring devicesto detect cardiac arrhythmias From Medtronic and MedCity News Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and helps improve the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms.  To learn more about AccuRhythm AI Platform, please click here to the download an infographic explaining how it works. AstraZeneca, Daiichi Sankyo have high hopes for drug that goes low in breast cancer By Frank Vinluan Monday, June 6, 2022 1:13 AM During the annual meeting of the American Society of Clinical Oncology, AstraZeneca and Daiichi Sankyo reported pivotal clinical trial data showing that their partnered cancer drug Enhertu can treat a group of patients previously thought to be out of reach for a targeted therapy. The results suggest use of this FDA-approved drug could significantly expand to more breast cancer patients. Read more » It's time to start innovating to make administrative data interoperable By Stuart Hanson Sunday, June 5, 2022 9:54 PM Just as with clinical interoperability, greater administrative interoperability could help eliminate many of the costs related to billing and insurance, freeing up much-needed investment resources. Read more » Gilead offers more detail on breast cancer drug's trial results. Is it enough? By Frank Vinluan Sunday, June 5, 2022 11:19 AM Gilead Sciences has more detail about breast cancer drug Trodelvy, a blockbuster hopeful it acquired two years ago. Additional data from a pivotal study were presented during the annual meeting of the American Society of Clinical Oncology and they still leave many questions unanswered. Read more » How identity segmentation can reduce the attack surface for healthcare organizations By Drex DeFord Sunday, June 5, 2022 10:02 AM One of the most effective methods to reduce the attack surface is segmentation. But, what type of segmentation should be used — network-centric or identity-centric? Read more » The shift from community dialysis to 'in-home' treatments at skilled nursing facilities By Allen Kaufman Sunday, June 5, 2022 10:00 AM The critical, pragmatic steps involved in developing patient-centric and equitable care for the nursing home patients came only very recently when medically advanced home hemodialysis therapies were repurposed and modified for use in the elderly frail nursing home dialysis patient populations Read more » Putting the 'Care' into Remote Healthcare RPM as we know it today – with all its advantages – falls short. The reason? Monitoring and alerting alone cannot provide one of the most critical parts of healthcare: care itself. Download this FREE white paper to learn more! MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails